Navigation Links
New sensors developed to predict effectiveness of radiotherapy treatment

The human population is exposed to both natural and artificial sources of radiation, which can cause cancer and other defects. Strangely, the same radiation that causes such effects is used for the treatment of cancer, //referred to as radiotherapy. It is however very difficult to assess if the precise dose of radiation is being delivered.

New sensor systems have now been developed that can assess the effectives of the radiation treatment to improve the accuracy and reliability. The system called as Intensity Modulated Radiotherapy (IMRT) has been developed for real-time radiation monitoring.

The setup sends the external beam radiation from different angles to different regions of the tumor. A collimator modulates and shapes the beams so that the tumour receives a uniform dose. It improves clinical outcomes by more accurately targeting tumors and minimizing the amount of radiation absorbed by healthy tissue.

INVORAD developed two sensors that can perform the task in a simple way. The small size of the sensor, the response to different forms of radiation used in radiotherapy and compatibility of the device with microprocessors offer a superior advantage. The device is based on the working principle of semiconductor material that senses the incoming radiation and transmits it to a display unit.

INVORAD also developed a cylindrical 'body phantom'. The 'phantom' is given the prescribed dose and the sensors pick up the dose actually delivered. If the 'phantom' treatment matches the prescription of the simulator, the patient is given treatment. If not, the treatment plan needs to be corrected.

The two devices are being tested in patients undergoing radiotherapy treatment. If successful, there would soon be commercialization of the sensor system. This is hoped to reduce the side effects patients associated with radiotherapy by improving accuracy of dose delivery, which has a significant impact in cancer tr eatment.
'"/>




Related medicine news :

1. New ways developed to understand dyslexia
2. Researchers developed world’s smallest toothbrus
3. Blood test developed for malignant hyperthermia
4. New ultralight hand with better functionality and flexibility developed
5. Novel antibiotic dressing developed for improved wound healing
6. New spinal surgery technique developed by UCSF Surgeon
7. Child specific HIV drugs and laboratory tests should be developed
8. Vaccines developed, to treat melanoma in dogs
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Vaccine for ear and sinus infections to be developed…
11. Canadians wait an eternity - Issues of a developed healthcare system.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... PA (PRWEB) , ... September 22, 2017 , ... ... soon as possible, and they often saves lives. However, if one isn’t accessible ... to widen the availability of defibrillation, I came up with this idea," said ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... House buildings, and Richard Pedranti Architect (RPA), a full-service architecture firm ... strategic partner’s Solsken Line of Model Homes . Independently, Ecocor and RPA ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Pennsylvania, is pleased to offer in-home and online newborn sleep consultations . ... has on the body,” says company owner Courtney Zentz, a pediatric sleep professional, ...
(Date:9/22/2017)... California (PRWEB) , ... September 22, 2017 , ... Happy ... at a time - carries it into the entertaining and delicious worlds of ... Matt Gersper (founder of Happy Living) convinced him to turn his play into a ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Healthcare Conference at the Grand Hyatt hotel in New ... 2017 at 11:40 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Medicine Technology: